Literature DB >> 15233640

Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.

H Broholm1, H Laursen.   

Abstract

Neuropilin-1 is a VEGF165- and semaphorin receptor expressed by endothelial cells and tumor cells. The specific function of neuropilin-1 is not fully known, but in the developing nervous system neuropilin, as a semaphorin receptor, has been shown to influence neuronal guidance. The expression of neuropilin-1 was studied in low-grade and high-grade astrocytic tumors, the latter characterized by extensive angiogenesis. We examined 20 low-grade astrocytomas (WHO grade II) and 46 glioblastomas (WHO grade IV) immunohistochemically for neuropilin-1, p53 and EGFR. The glioblastomas were according to the p53 and EGFR expression classified as 35 primary--de novo--glioblastomas, 9 secondary glioblastomas, and 2 uncertain cases. Furthermore, the presence of mast cells was evaluated to search for any potential function in angiogenesis. The glioblastomas expressed neuropilin-1 in the endothelial cells of the proliferating vessels and the majority of the glioblastomas had immunoreactive neoplastic astrocytes, with no difference between the glioblastoma subgroups. Six out of twenty of the low-grade astrocytomas were negative in the endothelial cells and 8 out of 20 in the tumor cells for neuropilin-1. Mast cells were observed in the collagen matrix around larger vessels in the leptomeninges, but not adjacent to malignant tumor vessels or as part of the tumor process itself. Increased expression of neuropilin-1 is shown in endothelial cells and in neoplastic astrocytes of glioblastomas. Less neuropilin-1 expression is found in about half of the low-grade astrocytomas in both neoplastic astrocytes and endothelial cells. The results suggest a correlation between neuropilin-1 and vascularity in human astrocytic tumors and a possible role for neuropilin-1 as a receptor for VEGF-induced angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233640     DOI: 10.1111/j.1600-0463.2004.apm11204-0505.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  17 in total

1.  Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.

Authors:  Hua Zhang; Sarah Tam; Elizabeth S Ingham; Lisa M Mahakian; Chun-Yen Lai; Spencer K Tumbale; Tambet Teesalu; Neil E Hubbard; Alexander D Borowsky; Katherine W Ferrara
Journal:  Biomaterials       Date:  2015-04-16       Impact factor: 12.479

2.  Secretome signature of invasive glioblastoma multiforme.

Authors:  Catherine A Formolo; Russell Williams; Heather Gordish-Dressman; Tobey J MacDonald; Norman H Lee; Yetrib Hathout
Journal:  J Proteome Res       Date:  2011-05-31       Impact factor: 4.466

Review 3.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

4.  Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.

Authors:  Eric E Paoli; Elizabeth S Ingham; Hua Zhang; Lisa M Mahakian; Brett Z Fite; M Karen Gagnon; Sarah Tam; Azadeh Kheirolomoom; Robert D Cardiff; Katherine W Ferrara
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

Review 5.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

Review 6.  Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.

Authors:  Karl H Plate; Alexander Scholz; Daniel J Dumont
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

7.  Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.

Authors:  Hu-bing Wu; Zhen Wang; Quan-shi Wang; Yan-jian Han; Meng Wang; Wen-lan Zhou; Hong-sheng Li
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

8.  Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

Authors:  L Karayan-Tapon; M Wager; J Guilhot; P Levillain; C Marquant; J Clarhaut; V Potiron; J Roche
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

9.  Alteration of blood-brain barrier integrity by retroviral infection.

Authors:  Philippe V Afonso; Simona Ozden; Marie-Christine Cumont; Danielle Seilhean; Luis Cartier; Payam Rezaie; Sarah Mason; Sophie Lambert; Michel Huerre; Antoine Gessain; Pierre-Olivier Couraud; Claudine Pique; Pierre-Emmanuel Ceccaldi; Ignacio A Romero
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

10.  Neuropilins: a new target for cancer therapy.

Authors:  Camille Grandclement; Christophe Borg
Journal:  Cancers (Basel)       Date:  2011-04-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.